A larger percentage of weight loss regained after an intensive lifestyle intervention was positively associated with certain cardiometabolic risk factors in type 2 diabetes.
Obesity rate has held steady in recent years.
Study informs guidance for ranges of safe, unsafe weight gain in twin pregnancies.
Receiving 12 weeks of probiotic supplement can improve body mass index as well as components of the inflammatory and glycolipid metabolism in obese children.
Findings seen for increased consumption of total nuts as well as walnuts, other tree nuts, peanuts.
Consumption of locally produced food without additives is associated with reduced blood pressure and visceral fat, as well as with improved mood.
Plus, statistically significant increases seen in adult obesity rates in 33 states between 2013 and 2018.
Central, but not overall, obesity linked to obstructive coronary artery disease underlying stable chest pain.
The AACE has produced a position statement addressing population-specific challenges and practical steps for clinicians with regard to diabetes care for African Americans, Latinx/Hispanics, Asian Americans, and Native Americans.
Large study shows particular increase in the 50- to 64-year-old age group from 2000 to 2016.
Patients with T2D and obesity who monitored their blood glucose more frequently had better outcomes after a 12-week intensive weight management program.
Interventions producing sustained weight loss of 25 to 30% of body weight recommended.
Investigators analyzed the link among maternal obesity, newborn size, and development of childhood cancer.
Greater variability tied to higher risk, independent of mean levels for BMI, HDL cholesterol in childhood.
Therapeutic weight loss is significantly associated with favorable hemodynamic effects in patients with obesity without a history of heart failure.
Normal weight with central obesity tied to higher risk of cardiovascular disease and cancer mortality.
Patients with severe obesity and gastroesophageal reflux disease may not experience long-term symptom relief from gastric bypass.
Larger effects seen for people from lower-income households.
Obese patients have significantly more relapses on first-line treatment with IFN beta, glatiramer acetate.
Prevalence decreased from 2010 to 2016 for children aged 2 through 4 enrolled in WIC.